Nasdaq: ROIV
Roivant Sciences insiders
The officers, directors and 10% owners of Roivant Sciences Ltd. who hold the most stock, valued at the live ROIV price.
$38.96
ROIV today +$230K (+0.59%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 13
- Their ROIV stock
- $8.90B
- Market value
- $27.94B
- Held by ranked insiders
- 31.8%
Insiders by value of ROIV holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Dan Oren | 10% owner | 102,849,443 | $4.01B | 14.3% | 78th |
| 2 | Vivek Ramaswamy | 10% owner | 47,011,612 | $1.83B | 6.56% | 153rd |
| 3 | Daniel Allen Gold | Director | 18,618,092 | $725M | 2.60% | 279th |
| 4 | Mayukh Sukhatme | President & CIO | 18,396,703 | $717M | 2.57% | 352nd |
| 5 | Matthew Gline | CEO | 16,391,229 | $639M | 2.29% | 334th |
| 6 | Frank Torti | President and Vant Chair | 12,306,950 | $479M | 1.72% | 475th |
| 7 | Keith Manchester | Director | 11,405,734 | $444M | 1.59% | 519th |
| 8 | Eric Venker | President & Immunovant CEO | 811,211 | $31.6M | 0.11% | 3014th |
| 9 | Richard Pulik | CFO | 222,046 | $8.7M | <0.1% | 9782nd |
| 10 | Rakhi Kumar | Chief Accounting Officer | 162,306 | $6.3M | <0.1% | 12022nd |
| 11 | James C. Momtazee | Director | 112,265 | $4.4M | <0.1% | 7605th |
| 12 | Andrew Lo | Director | 52,142 | $2.0M | <0.1% | 10957th |
| 13 | Meghan FitzGerald | Director | 41,162 | $1.6M | <0.1% | 12603rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Roivant Sciences; see each profile for the filing.